COMPANY OVERVIEW

None

---

LOCATION

---

THERAPEUTIC AREAS

---

WEBSITE

https://www.versantis.ch/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

PRESS RELEASES

Jun 24, 2022

Versantis Presents New VS-01 Data at The International Liver CongressTM 2022

Apr 13, 2022

Versantis Awarded Innosuisse Grant of CHF475,000 to Develop Point of Care Device to Monitor Blood Ammonia in Liver Disease Patients

Dec 20, 2021

Versantis Appoints Mark Fitzpatrick, Seasoned Biotech Executive, as its New CEO

Nov 15, 2021

Versantis to Present Positive Phase 1b Data at AASLD for VS-01 in Patients with Decompensated Cirrhosis

Oct 19, 2021

Versantis Appoints Leading Hepatologist Prof Dr Katharina Staufer as Chief Medical Officer

For More Press Releases

---